BRAF and melanoma: Interestingly, both groups of melanoma cell lines, those containing BRAFV600E and those wild-type for BRAF, showed significant inhibition of cell division following vemurafenib treatment compared to controls (Fig. 3C and 3D), although the inhibitory effect was most pronounced in the BRAFV600E lines.